Nevro Corp. (NVRO): Price and Financial Metrics

Nevro Corp. (NVRO): $18.82

1.50 (+8.66%)

POWR Rating

Component Grades








NVRO Price/Volume Stats

Current price $18.82 52-week high $46.71
Prev. close $17.32 52-week low $13.98
Day low $17.08 Volume 3,082,400
Day high $19.60 Avg. volume 579,094
50-day MA $16.86 Dividend yield N/A
200-day MA $24.35 Market Cap 681.38M

NVRO Stock Price Chart Interactive Chart >


  • Value is the dimension where NVRO ranks best; there it ranks ahead of 67.04% of US stocks.
  • NVRO's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • NVRO ranks lowest in Momentum; there it ranks in the 9th percentile.

NVRO Stock Summary

  • NVRO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.08 -- higher than only 2.08% of US-listed equities with positive expected earnings growth.
  • Over the past twelve months, NVRO has reported earnings growth of -6,340.87%, putting it ahead of merely 0.36% of US stocks in our set.
  • In terms of volatility of its share price, NVRO is more volatile than 81.2% of stocks we're observing.
  • Stocks that are quantitatively similar to NVRO, based on their financial statements, market capitalization, and price volatility, are ALL, FLR, CLMT, SQSP, and XPOF.
  • Visit NVRO's SEC page to see the company's official filings. To visit the company's web site, go to

NVRO Valuation Summary

  • In comparison to the median Healthcare stock, NVRO's price/sales ratio is 61.11% lower, now standing at 1.4.
  • NVRO's price/sales ratio has moved down 20.2 over the prior 109 months.

Below are key valuation metrics over time for NVRO.

Stock Date P/S P/B P/E EV/EBIT
NVRO 2023-11-03 1.4 2.0 -5.7 -7.5
NVRO 2023-11-02 1.3 1.9 -5.3 -7.1
NVRO 2023-11-01 1.3 1.9 -5.2 -6.9
NVRO 2023-10-31 1.2 1.8 203.4 61.0
NVRO 2023-10-30 1.2 1.7 199.8 60.2
NVRO 2023-10-27 1.2 1.8 203.5 61.1

NVRO Growth Metrics

    Its 2 year revenue growth rate is now at -2.39%.
  • The 4 year revenue growth rate now stands at 54.95%.
  • Its 2 year cash and equivalents growth rate is now at -63.51%.
NVRO's revenue has moved up $5,026,000 over the prior 33 months.

The table below shows NVRO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 395.281 22.939 -7.941
2022-06-30 388.02 -71.773 -139.524
2022-03-31 386.137 -63.428 -136.124
2021-12-31 386.905 -41.881 -131.36
2021-09-30 393.876 -14.863 -108.355
2021-06-30 409.131 11.835 -68.265

NVRO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NVRO has a Quality Grade of C, ranking ahead of 65.95% of graded US stocks.
  • NVRO's asset turnover comes in at 0.556 -- ranking 79th of 186 Medical Equipment stocks.
  • CSII, KRMD, and BIOL are the stocks whose asset turnover ratios are most correlated with NVRO.

The table below shows NVRO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.556 0.700 -0.058
2021-03-31 0.469 0.693 -0.084
2020-12-31 0.521 0.690 -0.093
2020-09-30 0.596 0.690 -0.124
2020-06-30 0.673 0.689 -0.160
2020-03-31 0.867 0.697 -0.146

Nevro Corp. (NVRO) Company Bio

Nevro Corporation develops and commercializes a neuromodulation platform for the treatment of chronic pain. The company was founded in 2006 and is founded in Menlo Park, California.

NVRO Latest News Stream

Event/Time News Detail
Loading, please wait...

NVRO Latest Social Stream

Loading social stream, please wait...

View Full NVRO Social Stream

Latest NVRO News From Around the Web

Below are the latest news stories about NEVRO CORP that investors may wish to consider to help them evaluate NVRO as an investment opportunity.

Wall Street Analysts Predict a 36.66% Upside in Nevro (NVRO): Here's What You Should Know

The mean of analysts' price targets for Nevro (NVRO) points to a 36.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 23, 2023

Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment

Nevro's (NVRO) latest 24-month data demonstrates the benefits of high-frequency 10 kHz SCS therapy for lasting pain relief, enhanced function, quality of life and reduced opioid dependency.

Yahoo | November 21, 2023

Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new 24-month data from the SENZA Nonsurgical Refractory Back Pain (NSRBP) multicenter randomized controlled trial (RCT) in the Journal of Neurosurgery: Spine.

Yahoo | November 20, 2023

Nevro Insiders Still US$51k Away From Original Investment Value

Insiders who bought US$171.6k worth of Nevro Corp. ( NYSE:NVRO ) stock in the last year recovered part of their losses...

Yahoo | November 4, 2023

Nevro Corp. (NYSE:NVRO) Q3 2023 Earnings Call Transcript

Nevro Corp. (NYSE:NVRO) Q3 2023 Earnings Call Transcript November 1, 2023 Nevro Corp. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.77. Operator: Hello. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to Nevro Third Quarter 2023 Financial Results Conference Call. […]

Yahoo | November 2, 2023

Read More 'NVRO' Stories Here

NVRO Price Returns

1-mo 28.90%
3-mo -7.70%
6-mo -33.43%
1-year -60.71%
3-year -88.35%
5-year -54.66%
YTD -52.47%
2022 -51.15%
2021 -53.17%
2020 47.27%
2019 202.24%
2018 -43.67%

Continue Researching NVRO

Here are a few links from around the web to help you further your research on Nevro Corp's stock as an investment opportunity:

Nevro Corp (NVRO) Stock Price | Nasdaq
Nevro Corp (NVRO) Stock Quote, History and News - Yahoo Finance
Nevro Corp (NVRO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!